Mirae Asset Global Investments Co., Ltd. Halozyme Therapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$28 Billion
Q2 2025

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,760 shares of HALO stock, worth $316,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,760

Previous 4,121 15.51%

Holding current value

$316,397

Previous $262,000 5.73%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 21, 2025	BUY	$47.91 - $70.14 $30,614 - $44,819	639 Added 15.51%	4,760 $247,000
Q1 2025 Apr 24, 2025	SELL	$47.74 - $65.16 $5,681 - $7,754	-119 Reduced 2.81%	4,121 $262,000
Q4 2024 Jan 27, 2025	SELL	$42.57 - $61.09 $14,558 - $20,892	-342 Reduced 7.46%	4,240 $202,000
Q3 2024 Oct 23, 2024	BUY	$51.3 - $64.42 $40,116 - $50,376	782 Added 20.58%	4,582 $262,000
Q2 2024 Jul 30, 2024	SELL	$37.81 - $52.4 $2.83 Million - $3.92 Million	-74,864 Reduced 95.17%	3,800 $198,000
Q1 2024 May 01, 2024	BUY	$33.68 - $41.95 $73,826 - $91,954	2,192 Added 2.87%	78,664 $3.2 Million
Q4 2023 Jan 24, 2024	BUY	$33.32 - $42.1 $22,457 - $28,375	674 Added 0.89%	76,472 $2.83 Million
Q3 2023 Oct 26, 2023	BUY	$36.46 - $44.03 $77,987 - $94,180	2,139 Added 2.9%	75,798 $2.9 Million
Q2 2023 Aug 10, 2023	SELL	$30.28 - $38.74 $125,056 - $159,996	-4,130 Reduced 5.31%	73,659 $2.66 Million
Q1 2023 May 04, 2023	BUY	$32.86 - $55.7 $400,333 - $678,593	12,183 Added 18.57%	77,789 $2.97 Million
Q4 2022 Feb 09, 2023	BUY	$40.06 - $59.44 $3,084 - $4,576	77 Added 0.12%	65,606 $3.73 Million
Q3 2022 Nov 10, 2022	BUY	$38.53 - $51.78 $625,958 - $841,217	16,246 Added 32.96%	65,529 $2.59 Million
Q2 2022 Jul 26, 2022	BUY	$37.35 - $48.3 $1.84 Million - $2.38 Million	49,283 New	49,283 $2.17 Million
Q4 2021 Feb 08, 2022	SELL	$31.82 - $40.75 $264,806 - $339,121	-8,322 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $41,586 - $50,180	1,081 Added 14.93%	8,322 $339,000
Q2 2021 Aug 11, 2021	SELL	$38.84 - $51.31 $4,777 - $6,311	-123 Reduced 1.67%	7,241 $329,000
Q1 2021 May 13, 2021	SELL	$39.51 - $51.45 $63,808 - $83,091	-1,615 Reduced 17.99%	7,364 $307,000
Q4 2020 Feb 10, 2021	BUY	$25.81 - $43.62 $12,053 - $20,370	467 Added 5.49%	8,979 $384,000
Q3 2020 Nov 12, 2020	BUY	$25.74 - $29.63 $219,098 - $252,210	8,512 New	8,512 $224,000

Others Institutions Holding HALO

# of Institutions

621

Shares Held

127M

Call Options Held

408K

Put Options Held

388K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.26B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Halozyme Therapeutics, Inc. Transaction History